Heparin Prophylaxis Dosing for Antepartum Hospitalizations (HEPDOSE)
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This study is a randomized control trial to compare gestational age-based dosing with
standard dosing of unfractionated heparin for thromboprophylaxis of hospitalized antepartum
patients. The investigators aim to determine the effect of dosing on receipt of neuraxial
anesthesia and pregnancy outcomes and evaluate the pharmacokinetics and pharmacodynamics of
unfractionated heparin in pregnancy.